Cytokinetics

CYTKNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.551 B

$76.76 -5.67%

Close of 7 Aug 2026

Revenue

$88.0M

#2559 by revenue

Earnings

-$785.0M

Loss-making

Shares outstanding

139,023,418

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#36Dr Reddys LaboratoriesRDY$10.2B
#37Praxis Precision MedicinesPRAX$10.1B
#38CytokineticsCYTK$9.55B
#39Protagonist TherapeuticsPTGX$9.44B
#40Ionis PharmaceuticalsIONS$9.40B

Where these numbers come from

Share counts and financials for Cytokinetics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.